Key facts
- Mike Mensinger, Chief Product Officer at Beta bionics, sold stock.
- The value of the stock sale was $55,193.
- The sale took place on Monday.
Mike Mensinger, the Chief Product Officer for Beta bionics, has sold a portion of his holdings in the company. The transaction, which occurred on Monday, amounted to $55,193. This type of insider transaction is often monitored by investors for signals about executive confidence in the company's future prospects.